Kovitz Investment Group Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.49M | Buy |
94,033
+19,851
| +27% | +$1.37M | 0.03% | 393 |
|
|
2025
Q1 | $5.15M | Buy |
74,182
+4,722
| +7% | +$328K | 0.03% | 403 |
|
|
2024
Q4 | $5.98M | Sell |
69,460
-12,594
| -15% | -$1.08M | 0.03% | 366 |
|
|
2024
Q3 | $8.96M | Buy |
82,054
+42,389
| +107% | +$4.63M | 0.06% | 248 |
|
|
2024
Q2 | $5.67M | Buy |
+39,665
| New | +$5.67M | 0.05% | 265 |
|
|
2021
Q4 | – | Sell |
-16,618
| Closed | -$798K | – | 433 |
|
|
2021
Q3 | $798K | Buy |
16,618
+506
| +3% | +$24.3K | 0.02% | 317 |
|
|
2021
Q2 | $675K | Buy |
+16,112
| New | +$675K | 0.01% | 335 |
|